FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP).

MLA

Nguyen, P. L., et al. “FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP).” International Journal of Radiation Oncology, Biology, Physics, vol. 117, no. 2, Oct. 2023, pp. S81–82. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2023.06.401.

APA

Nguyen, P. L., Kollmeier, M. A., Rathkopf, D., Hoffman, K. E., Zurita-Saavedra, A., Spratt, D. E., Dess, R. T., Liauw, S., Szmulewitz, R., Einstein, D. J., Bubley, G., Yu, J. B., An, Y., Wong, A. C., Feng, F. Y., Mckay, R. R., Rose, B. S., Shin, K. Y., Kibel, A., & Taplin, M. E. A. (2023). FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP). International Journal of Radiation Oncology, Biology, Physics, 117(2), S81–S82. https://doi.org/10.1016/j.ijrobp.2023.06.401

Chicago

Nguyen, P.L., M.A. Kollmeier, D. Rathkopf, K.E. Hoffman, A. Zurita-Saavedra, D.E. Spratt, R.T. Dess, et al. 2023. “FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP).” International Journal of Radiation Oncology, Biology, Physics 117 (2): S81–82. doi:10.1016/j.ijrobp.2023.06.401.